JAMA Medical News cover image

Highlights From the 2023 American Society of Clinical Oncology Annual Meeting

JAMA Medical News

00:00

The Potential Benefits of Nivolomab Immunotherapy for Patients With Advanced Hodgical Lymphoma

Only six patients in the entire trial needed that extra radiation boost after treatment. The benefit of the nivolomab was seen across all subgroups, every place that they stratified old versus young. It looks like this may be heading toward potential new standard of care treatment.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app